BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20160101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180914T100000
DTEND;TZID=America/New_York:20180914T113000
DTSTAMP:20260403T213003
CREATED:20180907T202401Z
LAST-MODIFIED:20180907T202401Z
UID:1785-1536919200-1536924600@carb-x.org
SUMMARY:FDA Commissioner Unveils Plan to Combat Antibiotic Resistance - Live Webcast
DESCRIPTION:At least 2 million Americans a year contract an antibiotic-resistant infection\, the Centers for Disease Control and Prevention reports. So\, what can the U.S. do to safeguard public health amid the growing threat of these superbugs? \nTune in to a live webcast as Dr. Scott Gottlieb\, commissioner of the U.S. Food and Drug Administration\, announces the agency’s plans to combat antibiotic resistance. \nFollowing Gottlieb’s remarks\, a panel of FDA senior officials will discuss aspects of the plan in more detail and take questions from the audience.
URL:https://carb-x.org/event/fda-commissioner-unveils-plan-to-combat-antibiotic-resistance-live-webcast/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180911T110000
DTEND;TZID=America/New_York:20180911T120000
DTSTAMP:20260403T213003
CREATED:20180829T152008Z
LAST-MODIFIED:20180829T152008Z
UID:1770-1536663600-1536667200@carb-x.org
SUMMARY:Antibacterial drugs: Clinical development for non-developers Webinar
DESCRIPTION:Part 2: Development of antibacterial drugs targeting specific pathogens \nThe overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. Our first webinar was devoted to more traditional approaches (Tiers A and B)\, best suited for more broad-spectrum products\, where the risks are lower. In this webinar\, we will discuss the development of products that target a single species of bacteria where the risks may be higher. While development of therapies for infections caused by a single bacterial species that is identified relatively frequently at a given body site of infection (e.g. Staphylococcus aureus (or even MRSA) in acute bacterial skin and skin structure infections) makes for readily feasible trials\, this is not the case for infrequently occurring infections such as those caused by Pseudomonas aeruginosa or Acinetobacter baumannii. Under these circumstances\, a clinical development program can be very challenging. This webinar will give an overview of the practical challenges associated with developing a therapy for a low frequency event for which treatment must be initiated urgently. The presentation will be followed by an interactive Q&A session. \n 
URL:https://carb-x.org/event/antibacterial-drugs-clinical-development-for-non-developers-webinar/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180905T080000
DTEND;TZID=America/New_York:20180905T170000
DTSTAMP:20260403T213003
CREATED:20180823T202625Z
LAST-MODIFIED:20180823T202625Z
UID:1763-1536134400-1536166800@carb-x.org
SUMMARY:Vaccines Against Clostridium difficile Infection (CDI): A Roadmap for the Future
DESCRIPTION:There are 453K new C. difficile infections (CDI) every year and 83K recurrent infections\, yet there are no licensed vaccines against this important nosocomial pathogen. The current pipeline of clinical-stage vaccines consists of two toxin-based candidates and one phase 3 candidate\, which is no longer being pursued. Although mathematical studies and computer-simulation models suggest that a CDI vaccine would be a cost-effective approach to protect against disease\, the overall public health impact for a CDI vaccine remains unclear. Moreover\, there are gaps in our understanding of the mucosal immune responses against CDI and how immunity against nontoxin antigens can improve protection. This timely workshop will explore and identify high-priority knowledge gaps in C. difficile pathogenesis and immunology in order to establish a path for future CDI vaccine development\, while considering the public health impact of introducing a licensed vaccine based on anti-toxin immunity.
URL:https://carb-x.org/event/vaccines-against-clostridium-difficile-infection-cdi-a-roadmap-for-the-future/
LOCATION:NIAID Conference Center\, 5601 Fishers Lane\, Rockville\, MD\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180904T080000
DTEND;TZID=UTC:20180907T170000
DTSTAMP:20260403T213003
CREATED:20180508T182444Z
LAST-MODIFIED:20180709T150858Z
UID:1357-1536048000-1536339600@carb-x.org
SUMMARY:ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
DESCRIPTION:Drug development for AMR is a rapidly moving field. The stakes are high. A difficult riskbenefit balance must be struck. There are relatively few new classes of antibiotics and each requires highly skilled and experienced investigators to ensure these compounds reach patients. This meeting is the forum where those issues are discussed and debated.
URL:https://carb-x.org/event/escmid-asm-conference-on-drug-development-to-meet-the-challenge-of-antimicrobial-resistance/
LOCATION:Intercontinental Lisbon\, R. Castilho 149\, Lisbon\, 1099-024\, Portugal
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180823T120000
DTEND;TZID=UTC:20180823T130000
DTSTAMP:20260403T213003
CREATED:20180508T182232Z
LAST-MODIFIED:20180810T185121Z
UID:1354-1535025600-1535029200@carb-x.org
SUMMARY:Next Generation Dx Summit: Investment Plenary Panel - Changing Approaches to Sustainable Funding in Diagnostics
DESCRIPTION:Today\, many innovators in the diagnostics industry struggle for funding\, and yet news of large scale acquisitions or large (over $30M) funding rounds pops up regularly. How can innovators better understand the changing dynamics of the funding environment to succeed? How can investors know if they are getting exposed to the potentially best investments? Whether government or private\, what drives the final difficult decisions and how can companies raise their chances of success? This session features leaders from several different channels of funding for innovators\, including the NIH\, other federal programs\, and corporate and traditional venture investors. \nModerator: Bruce Quinn\, MD\, PhD\, Principal\, Bruce Quinn Associates \nPanel includes Tyler Merkeley\, BARDA’s CARB-X Program Manager\, Health Scientist\, Division of CBRN Countermeasures\, BARDA.
URL:https://carb-x.org/event/next-generation-dx-summit-investment-plenary-panel/
LOCATION:Grand Hyatt Washington\, 1000 H St NW\, Washington\, DC\, 20001\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180821
DTEND;VALUE=DATE:20180823
DTSTAMP:20260403T213003
CREATED:20180725T185818Z
LAST-MODIFIED:20180810T185233Z
UID:1652-1534809600-1534982399@carb-x.org
SUMMARY:FDA Development of Non-Traditional Therapies for Bacterial Infections Workshop
DESCRIPTION:The Food and Drug Administration is holding a public workshop entitled “Development of Non-Traditional Therapies for Bacterial Infections.” The purpose of the public workshop is to discuss the general development considerations of non-traditional therapies\, including pre-clinical development\, early clinical studies\, and phase 3 clinical trial designs to evaluate safety and efficacy. \nPresentations by Kevin Outterson\, Executive Director of CARB-X\, and John Rex\, Chief Medical Officer of F2G Ltd.
URL:https://carb-x.org/event/fda-development-of-non-traditional-therapies-for-bacterial-infections-workshop/
LOCATION:FDA White Oak Campus – Building 31\, 10903 New Hampshire Ave\, Silver Spring\, MD\, 20993\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180809T083000
DTEND;TZID=America/New_York:20180809T123000
DTSTAMP:20260403T213003
CREATED:20180810T193055Z
LAST-MODIFIED:20180810T193147Z
UID:1716-1533803400-1533817800@carb-x.org
SUMMARY:Payment Reform Pathways for Antimicrobial Drugs: Duke-Margolis Center for Health Policy Roundtable Meeting
DESCRIPTION:Facilitating Payment Reform Pathways for Antimicrobial Drugs through FDA and CMS Collaboration \nAs you know\, the rise in antimicrobial resistant infections is a major public health threat. Few treatment options are available and the pipeline of drug candidates is extremely limited. To help address this issue\, Duke-Margolis has been focused on policy initiatives that could encourage development of antimicrobial products through post-market incentives. \nParticipants include Kevin Outterson\, Executive Director of CARB-X
URL:https://carb-x.org/event/payment-reform-pathways-for-antimicrobial-drugs/
LOCATION:Washington\, DC
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180626T110000
DTEND;TZID=America/New_York:20180626T123000
DTSTAMP:20260403T213003
CREATED:20180621T135932Z
LAST-MODIFIED:20180621T135932Z
UID:1585-1530010800-1530016200@carb-x.org
SUMMARY:GARDP Live Discussion Webinar: PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?
DESCRIPTION:
URL:https://carb-x.org/event/gardp-live-discussion-webinar-pk-pd-in-support-of-accelerated-programmes-for-antimicrobial-development-how-much-is-enough/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180614
DTEND;VALUE=DATE:20180615
DTSTAMP:20260403T213003
CREATED:20180508T181832Z
LAST-MODIFIED:20180508T181832Z
UID:1351-1528934400-1529020799@carb-x.org
SUMMARY:Understanding the Development Challenges Associated with Emerging Non-Traditional Antibiotics
DESCRIPTION:
URL:https://carb-x.org/event/understanding-the-development-challenges-associated-with-emerging-non-traditional-antibiotics/
LOCATION:JW Marriott Washington DC\, 1331 Pennsylvania Avenue NW\, Washington\, DC\, 20004\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20180613T173000
DTEND;TZID=Europe/Berlin:20180613T183000
DTSTAMP:20260403T213003
CREATED:20180607T153252Z
LAST-MODIFIED:20180607T153501Z
UID:1549-1528911000-1528914600@carb-x.org
SUMMARY:Webinar: Antibacterial Drugs: Clinical Development for Non-Developers Part 1 'Traditional development - tiers A and B
DESCRIPTION:
URL:https://carb-x.org/event/antibacterial-drugs-clinical-development-for-non-developers-part-1-traditional-development-tiers-a-and-b/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180607T080000
DTEND;TZID=UTC:20180611T170000
DTSTAMP:20260403T213003
CREATED:20180508T181344Z
LAST-MODIFIED:20180605T154930Z
UID:1348-1528358400-1528736400@carb-x.org
SUMMARY:ASM Microbe 2018 - Presentation by Karen Gallant
DESCRIPTION:
URL:https://carb-x.org/event/asm-microbe-2018/
LOCATION:Georgia World Congress Center\, 285 Andrew Young International Blvd NW\, Atlanta\, GA\, 30313\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180604
DTEND;VALUE=DATE:20180608
DTSTAMP:20260403T213003
CREATED:20180508T180912Z
LAST-MODIFIED:20180508T180912Z
UID:1345-1528070400-1528415999@carb-x.org
SUMMARY:BIO International Convention 2018
DESCRIPTION:
URL:https://carb-x.org/event/bio-international-convention-2018/
LOCATION:Boston Convention Center\, 415 Summer St\, Boston\, MA\, 02210\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180601T000000
DTEND;TZID=UTC:20180608T170000
DTSTAMP:20260403T213003
CREATED:20180508T192947Z
LAST-MODIFIED:20180509T004630Z
UID:1360-1527811200-1528477200@carb-x.org
SUMMARY:CARB-X welcomes on-line applications for funding of antibacterial projects
DESCRIPTION:CLICK HERE for Information on the scope of funding and how to apply
URL:https://carb-x.org/event/carb-x-welcomes-on-line-applications-for-funding-of-antibacterial-projects/
LOCATION:CARB-X\, 765 Commonwealth Ave\, Boston\, MA\, 02215\, United States
ORGANIZER;CN="CARB-X":MAILTO:carbx@bu.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180528
DTEND;VALUE=DATE:20180530
DTSTAMP:20260403T213003
CREATED:20180508T180326Z
LAST-MODIFIED:20180508T180326Z
UID:1342-1527465600-1527638399@carb-x.org
SUMMARY:Nature Biotechnology Conferences
DESCRIPTION:Kevin Outterson – presentor
URL:https://carb-x.org/event/nature-biotechnology-conferences/
LOCATION:Pullman Beijing South\, 12 Rong Hua Nan Lu\, Beijing\, 100176\, China
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180507T080000
DTEND;TZID=UTC:20180508T170000
DTSTAMP:20260403T213003
CREATED:20180202T015156Z
LAST-MODIFIED:20180419T235714Z
UID:948-1525680000-1525798800@carb-x.org
SUMMARY:Berlin Institute of Health - Charité Bih Entrepreneurship Summit
DESCRIPTION:Presenter: Kevin Outterson\nBerlin Institute of Health\nCharité Bih Entrepreneurship Summit\nBerlin\, Germany\n7-8 May 2018
URL:https://carb-x.org/event/berlin-institute-of-health-charite-bih-entrepreneurship-summit/
LOCATION:Berlin Institute of Health\, Anna-Louisa-Karsch-Straße 2\, Berlin\, 10178\, Germany
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180421T080000
DTEND;TZID=UTC:20180424T150000
DTSTAMP:20260403T213003
CREATED:20180202T014823Z
LAST-MODIFIED:20180419T235923Z
UID:946-1524297600-1524582000@carb-x.org
SUMMARY:28th European Congress of Clinical Microbiology and Infectious Diseases
DESCRIPTION:Presenter: John Rex\nESCMID\n28th European Congress of Clinical Microbiology and Infectious Diseases\nMadrid\, Spain\n21-24 Apr 2018
URL:https://carb-x.org/event/28th-european-congress-of-clinical-microbiology-and-infectious-diseases/
LOCATION:IFEMA – Feria de Madrid\, Avda. Del Partnon 5\, Madrid\, ESCMID Panorama ECCMID - The Society's annual congress ESCMID's yearly congress attracts over 12'000 participants. ECCMID offers a wide range of sessions including: keynotes\, symposia\, poster sessions\, educational workshops\, meet-the-expert sessions and more. 28th ECCMID 21 – 24 April 2018 Madrid\, Spain Abstract deadline 30 November 2017 Venue: IFEMA – Feria de Madrid Avda. Del Partnon 5 28042\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180319T083000
DTEND;TZID=UTC:20180320T170000
DTSTAMP:20260403T213003
CREATED:20180202T014550Z
LAST-MODIFIED:20180202T014639Z
UID:944-1521448200-1521565200@carb-x.org
SUMMARY:CME - Superbugs and Superdrugs 2018
DESCRIPTION:Presenter: Christopher Houchens\nCME\nSuperbugs and Superdrugs 2018\nLondon\n19-20 Mar 2018
URL:https://carb-x.org/event/cme-superbugs-and-superdrugs-2018/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180311T160000
DTEND;TZID=UTC:20180316T090000
DTSTAMP:20260403T213003
CREATED:20180202T014302Z
LAST-MODIFIED:20180202T014345Z
UID:941-1520784000-1521190800@carb-x.org
SUMMARY:Gordon Research Conference: Mechanisms Underlying Basal Ganglia Function and Dysfunction
DESCRIPTION:Presenter: John Rex\nGordon Research Conference\nMechanisms Underlying Basal Ganglia Function and Dysfunction\nVentura Beach\, CA\n11-16 Mar 2018
URL:https://carb-x.org/event/mechanisms-underlying-basal-ganglia-function-and-dysfunction/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180307T080000
DTEND;TZID=UTC:20180308T170000
DTSTAMP:20260403T213003
CREATED:20180202T011252Z
LAST-MODIFIED:20180202T014045Z
UID:938-1520409600-1520528400@carb-x.org
SUMMARY:Transatlantic Taskforce on Antimicrobial Resistance
DESCRIPTION:Presenter: Kevin Outterson\nTATFAR\nTransatlantic Taskforce on Antimicrobial Resistance\nAtlanta\, Georgia
URL:https://carb-x.org/event/transatlantic-taskforce-on-antimicrobial-resistance/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180305
DTEND;VALUE=DATE:20180306
DTSTAMP:20260403T213003
CREATED:20180202T010617Z
LAST-MODIFIED:20180202T010617Z
UID:934-1520208000-1520294399@carb-x.org
SUMMARY:Innovation Gaps on Life Science Frontiers?
DESCRIPTION:Presenter: Kevin Outterson\nNoVo Nordisk Foundation\nInnovation Gaps on Life Science Frontiers? From Antimicrobial Resistance & the Bad Bugs to New Uses\, AI & the Black Box\nCopenhagen\, Denmark
URL:https://carb-x.org/event/innovation-gaps-on-life-science-frontiers/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180302
DTEND;VALUE=DATE:20180303
DTSTAMP:20260403T213003
CREATED:20180202T010230Z
LAST-MODIFIED:20180202T010230Z
UID:932-1519948800-1520035199@carb-x.org
SUMMARY:11th Berlin Conference on Life Sciences: Novel Antimicrobial Conference and AMR Diagnostics
DESCRIPTION:Presenter: Kevin Outterson\nBEAM Alliance\n11th Berlin Conference on Life Sciences: Novel Antimicrobial Conference and AMR Diagnostics\nBerlin\, Germany
URL:https://carb-x.org/event/11th-berlin-conference-on-life-sciences-novel-antimicrobial-conference-and-amr-diagnostics/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180116T080000
DTEND;TZID=UTC:20180117T170000
DTSTAMP:20260403T213003
CREATED:20180202T011009Z
LAST-MODIFIED:20180202T011009Z
UID:936-1516089600-1516208400@carb-x.org
SUMMARY:Next Generation Antibiotic Workshop: Transforming Discovery
DESCRIPTION:Presenters:\nKevin Outterson\nJohn Rex\nUK Catapult Conference\nNext Generation Antibiotic Workshop: Transforming Discovery\nLondon\,\nUnited Kingdom
URL:https://carb-x.org/event/next-generation-antibiotic-workshop-transforming-discovery/
LOCATION:MA
ORGANIZER;CN="Mary Smith":MAILTO:rmj.scribbins@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20171108T080000
DTEND;TZID=UTC:20171108T170000
DTSTAMP:20260403T213003
CREATED:20180202T205906Z
LAST-MODIFIED:20180202T210006Z
UID:956-1510128000-1510160400@carb-x.org
SUMMARY:Powered by CARB-X: How CARB-X is Accelerating Antibacterial Innovation
DESCRIPTION:Presenters:\nTyler Merkeley\, Joe Larsen\, Chris Houchens\, Heather Shane & Lynn Marks\nBARDA Industry Day\nPowered by CARB-X: How CARB-X is Accelerating Antibacterial Innovation\nThe goal of the breakout meeting is to provide an overview on the CARB-X model and provide both industry and BARDA perspective of what it means to be “Powered by CARB-X”.\nWashington DC\n8 Nov 2017
URL:https://carb-x.org/event/powered-by-carb-x-how-carb-x-is-accelerating-antibacterial-innovation/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20171107T080000
DTEND;TZID=UTC:20171107T170000
DTSTAMP:20260403T213003
CREATED:20180202T210106Z
LAST-MODIFIED:20180202T210106Z
UID:958-1510041600-1510074000@carb-x.org
SUMMARY:Challenge Prize Center-Prize Advisory Panel Meeting
DESCRIPTION:Presenter: Kevin Outterson\nChallenge Prize Center\nPrize Advisory Panel Meeting\nLondon\, England\n7 Nov 2017
URL:https://carb-x.org/event/challenge-prize-center-prize-advisory-panel-meeting/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20171102T080000
DTEND;TZID=UTC:20171102T170000
DTSTAMP:20260403T213003
CREATED:20180202T210210Z
LAST-MODIFIED:20180202T210210Z
UID:960-1509609600-1509642000@carb-x.org
SUMMARY:2017 BioInfect Conference - State of the Nation
DESCRIPTION:Tyler Merkeley\nBioNow\n2017 BioInfect Conference – State of the Nation\nCheshire\, England\n2 Nov 2017
URL:https://carb-x.org/event/2017-bioinfect-conference-state-of-the-nation/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20171026T080000
DTEND;TZID=UTC:20171030T170000
DTSTAMP:20260403T213003
CREATED:20180202T210256Z
LAST-MODIFIED:20180202T210256Z
UID:962-1509004800-1509382800@carb-x.org
SUMMARY:World Conference of Science Journalists
DESCRIPTION:Kevin Outterson\nWorld Conference of Science Journalists\nBridging Science and Societies\nSan Francisco\, CA\n26-30 Oct 2017
URL:https://carb-x.org/event/world-conference-of-science-journalists/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20171018T080000
DTEND;TZID=UTC:20171020T170000
DTSTAMP:20260403T213003
CREATED:20180202T210344Z
LAST-MODIFIED:20180202T210344Z
UID:965-1508313600-1508518800@carb-x.org
SUMMARY:Re-Entering Antibacterial Discovery and Development Summit
DESCRIPTION:Tyler Merkeley\nRe-Entering Antibacterial Discovery and Development Summit @ Omni Parker House\nCARB-X: What does it mean to be Powered by CARB-X?\nBoston\, MA\n18-20 Oct 2017
URL:https://carb-x.org/event/re-entering-antibacterial-discovery-and-development-summit/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20171017T080000
DTEND;TZID=UTC:20171017T170000
DTSTAMP:20260403T213003
CREATED:20180202T210435Z
LAST-MODIFIED:20180202T210435Z
UID:967-1508227200-1508259600@carb-x.org
SUMMARY:Addressing Antimicrobial Resistance: New Research and Funding Opportunities
DESCRIPTION:Heather Shane\nBIO Investor Forum\nPanel: Addressing Antimicrobial Resistance: New Research and Funding Opportunities\nSan Francisco\, CA\n17 Oct 2017
URL:https://carb-x.org/event/addressing-antimicrobial-resistance-new-research-and-funding-opportunities/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20171016T080000
DTEND;TZID=UTC:20171016T170000
DTSTAMP:20260403T213003
CREATED:20180202T210804Z
LAST-MODIFIED:20180202T210815Z
UID:969-1508140800-1508173200@carb-x.org
SUMMARY:Forces Shaping the Future of Health & Healthcare
DESCRIPTION:Kevin Outterson\nIHSIP\nForces Shaping the Future of Health & Healthcare\nBoston\, MA\n16 Oct 2017
URL:https://carb-x.org/event/forces-shaping-the-future-of-health-healthcar/
LOCATION:MA
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20171004T080000
DTEND;TZID=UTC:20171004T170000
DTSTAMP:20260403T213003
CREATED:20180202T210857Z
LAST-MODIFIED:20180202T210857Z
UID:972-1507104000-1507136400@carb-x.org
SUMMARY:McDermott\, Will & Emery Life Sciences Dealmaking Symposium
DESCRIPTION:Tyler Merkeley\, Kevin Outterson & Dennis Dixon\nPanel: Non-Dilutive Funding and Other Unique Capital Sources\nMcDermott\, Will & Emery Life Sciences Dealmaking Symposium\nRoyal Sonesta Boston\nCambridge\, MA\n4 Oct 2017
URL:https://carb-x.org/event/mcdermott-will-emery-life-sciences-dealmaking-symposium/
LOCATION:MA
END:VEVENT
END:VCALENDAR